Biogen

BIIB US Health Care Biotechnology
S&P 500
$217.15
+0.80%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Biogen belong to?
Biogen operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of BIIB?
As of the latest available quote, BIIB traded at $217.15. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of BIIB?
Biogen has a price-to-earnings (P/E) ratio of about 38.64. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of BIIB?
The market capitalisation of Biogen is approximately $31.94B.
Is Biogen profitable?
For its latest reported financial year, Biogen recorded a net profit margin of about 13.07%.
Does BIIB pay a dividend?
Biogen does not currently show a dividend yield in our data.
What is the return on equity (ROE) of BIIB?
Biogen has a return on equity (ROE) of about 8.74%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of BIIB?
Over the past 52 weeks, BIIB has traded between a low of $135.39 and a high of $225.80.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.